Positron emission tomography molecular imaging-based cancer phenotyping

被引：21

作者：

Jin, Chentao ^{[1
,2
,3
,4
]}

Luo, Xiaoyun ^{[1
,2
,3
,4
]}

Li, Xiaoyi ^{[1
,2
,3
,4
]}

Zhou, Rui ^{[1
,2
,3
,4
]}

Zhong, Yan ^{[1
,2
,3
,4
]}

Xu, Zhoujiao ^{[1
,2
,3
,4
]}

Cui, Chunyi ^{[1
,2
,3
,4
]}

Xing, Xiaoqing ^{[1
,2
,3
,4
]}

Zhang, Hong ^{[1
,2
,3
,4
,5
,6
]}

Tian, Mei ^{[1
,2
,3
,4
]}

机构：

[1] Zhejiang Univ, Dept Nucl Med, Affiliated Hosp 2, Sch Med, Hangzhou, Peoples R China

[2] Zhejiang Univ, Positron Emiss Tomog Ctr, Affiliated Hosp 2, Sch Med, Hangzhou, Peoples R China

[3] Zhejiang Univ, Inst Nucl Med & Mol Imaging, Hangzhou, Peoples R China

[4] Key Lab Med Mol Imaging Zhejiang Prov, Hangzhou, Peoples R China

[5] Zhejiang Univ, Coll Biomed Engn & Instrument Sci, Hangzhou, Peoples R China

[6] Zhejiang Univ, Key Lab Biomed Engn, Minist Educ, Hangzhou, Peoples R China

来源：

CANCER | 2022年 / 128卷 / 14期

基金：

国家重点研发计划; 中国国家自然科学基金;

关键词：

biomarker; cancer; cancer hallmarks; molecular imaging; positron emission tomography (PET); translational medicine; TUMOR-ASSOCIATED MACROPHAGES; PROSTATE-CANCER; BREAST-CANCER; AMINO-ACIDS; PET; EXPRESSION; VISUALIZATION; REPORTER; RECEPTOR; INFLAMMATION;

D O I：

10.1002/cncr.34228

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

During the past several decades, numerous studies have provided insights into biological characteristics of cancer cells and identified various hallmarks of cancer acquired in the tumorigenic processes. However, it is still challenging to image these distinctive traits of cancer to facilitate the management of patients in clinical settings. The rapidly evolving field of positron emission tomography (PET) imaging has provided opportunities to investigate cancer's biological characteristics in vivo. This article reviews the current status of PET imaging on characterizing hallmarks of cancer and discusses the future directions of PET imaging strategies facilitating in vivo cancer phenotyping.

引用

页码：2704 / 2716

页数：13

共 50 条

[21] Positron emission tomography molecular imaging for drug development
Matthews, Paul M.
Rabiner, Eugenii A.
Passchier, Jan
Gunn, Roger N.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2012, 73 (02) : 175 - 186
[22] Molecular Imaging in Oncology Using Positron Emission Tomography
Derlin, Thorsten
Gruenwald, Viktor
Steinbach, Joerg
Wester, Hans-Juergen
Ross, Tobias L.
DEUTSCHES ARZTEBLATT INTERNATIONAL, 2018, 115 (11): : 175 - +
[23] Positron emission tomography: diagnostic imaging on a molecular level
Allemann, K
Wyss, M
Wergin, M
Bley, CR
Ametamay, S
Bruehlmeier, M
Kaser-Hotz, B
SCHWEIZER ARCHIV FUR TIERHEILKUNDE, 2004, 146 (08): : 359 - 364
[24] Positron emission tomography - molecular imaging of biological processes
Knuuti, J
QUANTITATION IN BIOMEDICAL IMAGING WITH PET AND MRI, 2004, (1265): : 248 - 254
[25] Positron emission tomography and molecular imaging of the prostate: an update
Lawrentschuk, N
Davis, ID
Bolton, DM
Scott, AM
BJU INTERNATIONAL, 2006, 97 (05) : 923 - 931
[26] Application of positron emission tomography imaging to cancer screening
S Yasuda
M Ide
H Fujii
T Nakahara
Y Mochizuki
W Takahashi
A Shohtsu
British Journal of Cancer, 2000, 83 : 1607 - 1611
[27] Update on positron emission tomography for imaging of prostate cancer
Kitajima, Kazuhiro
Murphy, Robert C.
Nathan, Mark A.
Sugimura, Kazuro
INTERNATIONAL JOURNAL OF UROLOGY, 2014, 21 (01) : 12 - 23
[28] Fluorinated tracers for imaging cancer with positron emission tomography
Olivier Couturier
André Luxen
Jean-François Chatal
Jean-Philippe Vuillez
Pierre Rigo
Roland Hustinx
European Journal of Nuclear Medicine and Molecular Imaging, 2004, 31 : 1182 - 1206
[29] Application of positron emission tomography imaging to cancer screening
Yasuda, S
Ide, M
Fujii, H
Nakahara, T
Mochizuki, Y
Takahashi, W
Shohtsu, A
BRITISH JOURNAL OF CANCER, 2000, 83 (12) : 1607 - 1611
[30] Imaging of Cancer Metabolism using Positron Emission Tomography
Yun, Mi Jin
Lee, Jong-Doo
JOURNAL OF THE KOREAN MEDICAL ASSOCIATION, 2009, 52 (02): : 113 - 120

← 1 2 3 4 5 →